pragma.vision Technology observatory

Verification register Bio, Health & Neuro

Readiness verdict

Science Corporation PRIMA Retinal Implant

A dated reading of what is claimed, reported, and independently verified in the current evidence.

As of
2026-07-23
Revision
1
Method
v1.3.0

Current reading

Readiness band and full integer triple

AI-assisted assembly · derived results

Readiness band

Ready

Primary summary from verified readiness

Confidence
54% · fresh
Computed at
2026-07-23T12:36:47.240808+00:00
Claimed
85

Public ambition and stated capability

Reported
77

Observed practitioner reporting

Verified
69

Independently supported evidence

Gap
+16

Claimed leads verified

Evidence strength Critical

Decision

What the current evidence supports

Human editorial judgment · 2026-07-23

Track; not yet

Why
Peer-reviewed efficacy (NEJM, tier 3) is strong and CE marking is real and verified, but the SAE rate (~50% of implanted patients), unresolved reimbursement, high per-unit cost, and narrow initial geography mean commercial-scale, cost-accessible deployment is not yet demonstrated — premature for any build/partnership action, appropriate only to monitor.
Next
Re-check after the first real-world (non-trial) commercial implants land in Germany (~Sept 2026) and after at least one European payer reimbursement decision is public; revisit claimedReadiness/observedActivity at the next register refresh.

Constraints

Blockers

No named blocker is present in the current public projection.

Evidence summary

Derived counts

AI-assisted assembly

Total
5
Tier 1
0
Tier 2
1
Tier 3
4
Supports
2
Contradicts
2
Context
1
Latest observed
2026-07-22

Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.

Publication record

Revisions

Initial public reading

  1. 2026-07-23 Reading moved from ready to ready.

Your opinion

Tell us anything.

What works, what doesn't, what's missing — especially about our watches, lenses, and the register itself. Anonymous is fine; leave an email if you'd like a reply.